Selective COX-2 inhibitors may pose a greater risk of hyperkalaemia than nonselective NSAIDs

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1325, 2010-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors that Influence Prescribers in their Selection and use of COX-2 Selective Inhibitors as Opposed to Non-selective NSAIDs*

By Gunnarsdóttir Anna Kinnear Moira

Pharmacy World and Science, Vol. 27, Iss. 4, 2005-08 ,pp. : 316-320

Springer Publishing Company

Access to resources Recommend Favorite

COX-2 inhibitors: lower risk of pancreatitis than other NSAIDs

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Selective COX-2 inhibitors vs NSAIDs discussed

Inpharma, Vol. 1, Iss. 1341, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

By Motsko Stephen P.

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite

COX-2s preferred over nonselective NSAIDs in coumarin recipients

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite